CHAPTER - IV. Acharya Nagarjuna University, Guntur 105
|
|
- Edith Mills
- 6 years ago
- Views:
Transcription
1 CHAPTER - IV Acharya Nagarjuna University, Guntur 105
2 A STABILITY-INDICATING LC METHOD FOR LENALIDOMIDE Lenalidomide, 3-(4-amino-1-oxo-3H-isoindol-2-yl) piperidine-2, 6-dione (fig. 4.1), is a novel oral immunomodulatory drug, with antiangiogenic and antineoplastic properties (Kastritis, E., 2007). It is structurally related to thalidomide but has an improved toxicity profile and more potent immunomodulatory activity (Mitsiades, C.S., 2004). Lenalidomide is currently being used in the treatment of hematological malignancies, particularly multiple myeloma (MM) and a subset of myelodysplastic syndrome (MDS) harboring the deletion 5q chromosome abnormality (Dimopoulos, M. A., 2005; Richardson, P. G., 2006; Weber, D., 2006; List, A., 2006;). 1. Experimental 1.1 Chemicals Lenalidomide and its related impurities (fig. 4.2a, 4.2b) were obtained from Natco Pharma Limited (Kothur, Hyderabad,India). Capsules containing 5, 10, 15 and 25 mg lenalidomide were obtained commercially. HPLC-grade acetonitrile and methanol was from Merck (Darmstadt, Germany). Analytical reagent-grade orthophosphoric acid and Triethylamine were from Merck. High-purity water was prepared by use of a Millipore MilliQ plus water-purification system. 1.2 Chromatography HPLC analysis for method development, forced degradation studies, and method validation was performed with a Waters 2695 binary pump plus auto-sampler and a Waters 2996 photodiode-array detector (PDA). The output signal was monitored and processed using Empower software resident in a Pentium computer (Digital Equipment). Compounds were separated on a Inertsil ODS -3V, (250 x 4.6 mm), 5 µm column with a 50:50 (v/v) mixture of orthophosphoric acid buffer, ph 3.0, and acetonitrile as mobile phase. The buffer was prepared from mix 1mL of orthophosphoric acid to 1000 ml of purified water. Adjust ph to 3.0 with triethylamine. Filter the solution through 0.45µ membrane filter. The injection volume was 15 µl, the mobile phase flow rate was 1.0 ml min -1, the column temperature was 30 C, and the detection wavelength was 240 nm. Acharya Nagarjuna University, Guntur 106
3 1.3 Preparation of solutions Standard solutions A stock solution of lenalidomide (5.0 mg ml -1 ) was prepared by dissolving an appropriate amount in acetonitrile. Working solutions containing (2.5 µg ml -1 ) were prepared from this stock solution for determination of related substances and for assay determination, respectively. A mixed stock solution (2.5 µg ml -1 ) of the impurities (Imp-A and Imp-B) was also prepared in acetonitrile Sample solution Twenty capsules were weighed, powder transferred to a clean, dry volumetric flask. Powder equivalent to 50 mg drug was then transferred to a 100 ml volumetric flask, 60 ml acetonitrile was added, and the flask was attached to a rotary shaker for 15 min to disperse the material completely. The mixture was then sonicated for 15 min and diluted to volume to give a solution containing (500 µg ml -1 ). This solution was centrifuged at 3,000 rpm for 5 min and 10 ml of the supernatant was diluted to 100 ml with acetonitrile, to give a solution containing (50 µg ml -1 ). This solution was filtered through a 0.45 µm pore size Nylon 66 membrane filter. 1.4 Specificity The specificity of a method is its suitability for analysis of a substance in the presence of potential impurities (I. C. H., 2003). Stress testing of a drug substance can help identify likely degradation products, which can, in turn, help establish degradation pathways and the intrinsic stability of the molecule. It can also be used to validate the stability-indicating power of the analytical procedures used. The specificity of the LC method for lenalidomide was determined in the presence of two impurities and degradation products. Forced degradation of lenalidomide was also performed to provide an indication of the stability indicating properties and specificity of the method (Bakshi, M., 2002; Carstensen, J. T., 2000). The stress conditions used for the degradation study included light (conducted as stipulated in ICH Q1B), heat (60 0 C), acid hydrolysis (0.1 M HCl), basic hydrolysis (0.1 M NaOH), aqueous hydrolysis, and oxidation (0.1% H2O2). For studies of the effects of heat and light the study period was 10 days whereas for acidic, basic, and aqueous Acharya Nagarjuna University, Guntur 107
4 hydrolysis and oxidation it was 48 h. The purity of peaks obtained from stressed samples of lenalidomide was checked by use of the PDA. The purity angle is within the purity threshold limit obtained in all stressed samples and demonstrates the analyte peak homogeneity. For all stressed samples of lenalidomide the chromatographic run time was extended to 300 min to check for late-eluting degradation products. Assay of stressed samples was performed by comparison with reference standards and the mass balance (% assay + % impurities + % degradation products) was calculated. Assay was also calculated for bulk samples and drug product by spiking with two impurities at the specification level (i.e. 0.15% of analyte concentration, which was (500µg ml -1 ). 1.5 Method validation Precision The precision of the related-substance method was checked by twofold analysis of (500 µg ml -1 ) lenalidomide spiked with 0.15% of each of the two impurities. The RSD (%) of peak area was calculated for each impurity. To evaluate the intermediate precision (ruggedness) of the method, analysis was performed by a different analyst using a different column and a different instrument in the same laboratory. The precision of the assay was evaluated by performing two independent assays of a test sample of lenalidomide and comparison with a reference standard. The RSD (%) of the two results was calculated Limits of detection (LOD) and quantification (LOQ) LOD and LOQ for the two impurities were estimated as the amounts for which the signal-to-noise ratios were 3:1 and 10:1, respectively, by injecting a series of dilute solutions of known concentration (I. C. H., 1995). Precision was also determined at the LOQ level by analysis of two individual preparations of the two impurities and calculating the RSD (%) of the peak area for each impurity Linearity To test the linearity of the method, solutions at two concentrations from 25 to 150% of the analyte concentration (0.051, 0.633, 1.266, 1.898, 2.531, and µg ml -1 ) were prepared from the stock solution. Least-squares linear regression analysis Acharya Nagarjuna University, Guntur 108
5 was performed on peak area and concentration data. Solutions for testing linearity for the related substances were prepared by diluting the impurity stock solution to two different concentrations from the LOQ to 150% of the permitted maximum level of the impurity (Imp-A: 0.050, 0.629, 1.257, 1.886, and and Imp-B: 0.052, 0.651, 1.302, 1.953, and µg ml -1 ). The correlation coefficients, slopes, and y-intercepts of the calibration plots are reported Accuracy The accuracy of the method for lenalidomide was evaluated in triplicate at three concentrations, 25, 50 and 75µg ml -1, both for bulk sample and drug product, and recovery was calculated. For the impurities, recovery was determined in triplicate for 50, 100 and 150% of the analyte concentration (500 µg ml -1 ), and recovery of the impurities was calculated. (The bulk sample did not contain Imp-A. It contained 0.01% Imp-B) Robustness To determine the robustness of the method the experimental conditions were deliberately changed and the resolution of lenalidomide and the two impurities was evaluated. The mobile phase flow rate was 1.0 ml / minute, to study the effect of flow rate on resolution it was changed to 0.8 and 1.2 ml / minute. The effect of ph was studied at ph 2.9 and 3.1 (instead of ph 3.0). The effect of column temperature was studied at 28 and 32 0 C (instead of 30 0 C). In all these experiments the mobile phase components were not changed Stability in solution and in the mobile phase The stability of lenalidomide in solution was determined by leaving test solutions of the sample and reference standard in tightly capped volumetric flasks at room temperature for 48 h during which they were assayed at 6 h intervals. Stability in the mobile phase was determined by analysis of freshly prepared sample solutions at 6 h intervals for 48 h and comparing the results with those obtained from freshly prepared reference standard solutions. The mobile phase was prepared at the beginning of the study period and not changed during the experiment. The RSD (%) of the results was calculated for both the mobile phase and solution-stability experiments. The stability of lenalidomide and its impurities in solution in the related Acharya Nagarjuna University, Guntur 109
6 substance method was determined by leaving spiked sample solution in a tightly capped volumetric flask at room temperature for 48 h and measuring the amounts of the two impurities every 6 h. The stability of lenalidomide and its impurities in the mobile phase was also determined by analysis of a solution of the two impurities every 6 h for 48 h. The mobile phase was not changed during the study period. 2. Results and discussion 2.1 Method development and optimization The main objective of the chromatographic method was to separate critical closely eluting impurities Imp-A and Imp-B and to elute lenalidomide as a symmetrical peak. When Inertsil C8 and Waters Symmetry C18 columns (both 250 x 4.6 mm, containing 5 µm particles) were used, lenalidomide was much too strongly retained (approx. 50 min) when the mobile phase flow rate was 1.0 ml min -1. Use of the 250 x 4.6 mm, 5 µm particle, Zorbax CN column reduced the retention of lenalidomide and its impurities. The resolution between Imp-A and Imp-B was 1.1. The tailing factor for the lenalidomide peak was very high (3.3) when orthophosphoric acid buffer ph was adjusted with triethylamine. To check the effect on resolution of the impurities, peak shape for lenalidomide and the impurities. Ammonium buffer (20 mm ammonium acetate adjusted to ph 7.2 with aqueous ammonia solution) was evaluated (buffer acetonitrile, 50:50, v/v) but this resulted in early elution of lenalidomide (retention time approx. 2.5 min) and co-elution of Imp- A and Imp-B. It was found that use of buffer prepared by adjusting the ph of 0.1% orthophosphoric acid to 3.0 with triethylamine (again buffer acetonitrile, 50:50, v/v) enabled separation of Imp-A and Imp-B and elution of lenalidomide as a symmetrical peak (fig. 4.3). Detailed results from the method-development trials are listed in table 4.1. At a column temperature of 30 0 C the peak shape of lenalidomide was symmetrical. When acetonitrile was used as blank there was no interference with the peaks of the two impurities or lenalidomide. Interference from the excipients (Anhydrous Lactose, empty hard gelatin capsule) was also checked by injection of solutions of these materials. No interference was observed (fig. 4.4). Under optimized conditions lenalidomide and the two impurities were well separated with resolution greater than two; typical retention times were approximately 8.7, 21.5 and 42.0 min Acharya Nagarjuna University, Guntur 110
7 for lenalidomide, Imp-B and Imp-A, respectively. Results from determination of system suitability are given in table 4.2. The method was found to be specific for lenalidomide and its impurities (table 4.3). Analysis was performed on different batches of bulk drug (n = 3) and on pharmaceutical dosage forms (n = 3). The results were given in table 4.4. Results from stability studies performed in accordance with ICH Q1A (R2) recommendations are given in tables 4.5 and Validation of the Method Precision RSD (%) in the study of the precision of the assay of lenalidomide was within 0.1%. RSD (%) of peak area for the two impurities in the study of the precision of the assay of the related substances was within 1.5%. These results confirmed the method was highly precise. RSD (%) for lenalidomide in the study of intermediate precision was 0.3%; for the two impurities RSD (%) of peak area was well within 2.0%. These results confirmed the ruggedness of the method (table 4.7) Limits of Detection and Quantification The limits of detection for Imp-A and Imp-B were, respectively, , and % of the concentration of lenalidomide, i.e µg ml -1, for a 15µL injection. The limits of quantification for Imp-A and Imp- B were, respectively, , and % of the concentration of the analyte, i.e µg ml -1, respectively, for a 15µL injection. Precision at the LOQ concentration for the two impurities was <2% Linearity The calibration plot for assay of lenalidomide was linear over the calibration range tested ( µg ml -1 ), and the correlation coefficient was > These results show there was an excellent correlation between the peak area and analyte concentration. The slope and y intercept of the calibration plot were and , respectively. Calibration plots for Imp-A (0.050 to µg ml -1 ) and Imp-B (052 to µg ml -1 ) were linear over the ranges tested. The correlation coefficients were > When linearity for the related substances was checked over the same concentration range for three consecutive days RSD (%) for the slopes and y intercepts of the Acharya Nagarjuna University, Guntur 111
8 calibration plots were 0.5 and 0.3, respectively. These results show there was an excellent correlation between the peak area and concentration for the two impurities Accuracy Recovery of lenalidomide from bulk drug samples ranged from to % (table 4.8) and that from pharmaceutical dosage forms ranged from to % (table 4.9). Recovery of the two impurities from bulk drug samples ranged from to 102.4% Robustness When mobile phase flow rate and ph, and column temperature were deliberately varied resolution between closely eluting impurities, i.e. between Imp-A and Imp-B, was greater than 2.0, illustrating the robustness of the method (table 4.10) Stability in Standard Solution and in the Mobile Phase RSD (%) for assay of lenalidomide during standard solution stability was within 1%. changes in the amounts of the two impurities were observed during solution stability, but sample in mobile phase are not stable at room temperature (25 C ± 2 C) and refrigerator condition (2 C 8 C). The results from standard solution stability experiments confirmed that for up to 48 h during assay and determination of related substances. Stability in the mobile phase was not with in the limit at room temperature and refrigerator and solutions were prepared freshly at the time of analysis Results from Forced Degradation Studies Degradation was not observed when lenalidomide was subjected to light and heat. Degradation was not observed when the drug substance was subjected to acidic, basic and to oxidative conditions (fig. 4.5). Lenalidomide is highly sensitive to aqueous hydrolysis and was degraded into Imp-B by basic for 48 h (fig. 4.6). This was confirmed by co-injection with Imp-B standard. Peak-purity test results from the PDA detector confirmed the lenalidomide peak obtained from all the stress samples analyzed was homogeneous and pure. Peak purity results from the PDA detector for the peaks produced by degradation of lenalidomide confirmed that all these peaks were homogeneous and pure for all the stress samples analyzed (fig. 4.7a- 4.7g). For Acharya Nagarjuna University, Guntur 112
9 all the stress conditions investigated no degradation product peaks were observed after 30 min in chromatograms acquired for the extended runtime of 300 min. The mass balance for the stressed samples was close to 99.6%. Assay of lenalidomide was unaffected by the presence of the two impurities / degradation products, confirming the stability-indicating power of the method. 3. Conclusions The isocratic RP-LC method developed for quantitative analysis of lenalidomide and related substances in both bulk drug and pharmaceutical dosage forms is precise, accurate, and specific. Satisfactory results were obtained from validation of the method. The method is stability indicating and can be used for routine analysis of production samples and to check the stability of samples of lenalidomide. Acharya Nagarjuna University, Guntur 113
10 Fig 4.1: Lenalidomide: 3-(7-Amino-3-oxo-1H-isoindol-2-yl) piperidine-2, 6-dione Fig 4.2a: Impurity-A: Methyl 2-bromomethyl-3-nitrobenzoate Fig 4.2b: Impurity-B: 3-(4-nitro-1-oxoisondolin-2-yl)-piperidine-2, 6 dione Acharya Nagarjuna University, Guntur 114
11 Fig 4.3: Typical chromatogram obtained under the optimum conditions from LLM spiked with impurities at the 0.15% level Acharya Nagarjuna University, Guntur 115
12 Fig 4.4: Typical chromatogram obtained from blank Acharya Nagarjuna University, Guntur 116
13 Fig 4.5: Typical chromatogram obtained from oxidative conditions stressed LLM samples Acharya Nagarjuna University, Guntur 117
14 Fig 4.6: Typical chromatogram obtained from aqueous hydrolysis stressed LLM samples Acharya Nagarjuna University, Guntur 118
15 Fig 4.7a: Control sample preparation Fig 4.7b: Treatment of sample with 0.1N HCl Acharya Nagarjuna University, Guntur 119
16 Fig. 4.7c: Treatment of sample with 0.025N NaOH Fig. 4.7d: Treatment of sample with 10 % H2O2 Acharya Nagarjuna University, Guntur 120
17 Fig. 4.7e: Treatment of sample with Purified Water Fig. 4.7f: Sensitivity to heat at 105 C Acharya Nagarjuna University, Guntur 121
18 Fig. 4.7g: Sensitivity to UV radiation at 254 nm Figure Peak purity results from the PDA detector for the peaks produced by degradation of lenalidomide for all the stress samples Acharya Nagarjuna University, Guntur 122
19 Trial no. HPLC conditions Remarks 1 Flow: 1.0 ml / minute Column: Inertsil C8, 250 x 4.6 mm, 5 µm particles. Mobile phase: 50:50 (v/v) buffer acetonitrile: buffer Prepared by adjusting 20mM sodium dihydrogen phosphate monohydrate to ph 3.0 by addition of trifluoroacetic acid 2 Flow: 1.0 ml / minute Column: Zorbax CN (250 mm 4.6) mm, 5 µm particles Mobile phase: 50:50 (v/v) buffer acetonitrile; buffer prepared by adjusting 20 mm sodium dihydrogen phosphate monohydrate to ph 3.0 by addition of phosphoric acid 3 Flow: 1.0 ml / minute Column: Zorbax CN (250 mm 4.6) mm, 5 µm particles Mobile phase: 50:50 (v/v) buffer acetonitrile; buffer prepared by adjusting 20 mm ammonium acetate to ph Flow: 1.0 ml min) Column: Zorbax CN (250 mm 4.6) mm, 5 µm particles Mobile phase: 50:50 (v/v) buffer acetonitrile; buffer prepared by adjusting 20 mm sodium dihydrogen phosphate monohydrate to ph 3.0 by addition of trifluoroacetic acid The retention times of lenalidomide and Imp- A were approximately 50alidomide and 120 min approximately 50 and 120 min The tailing factor of lenalidomide was 3.3; RS between Imp-B and Imp-3 was 1.1; RS between Imp-A andimp-4 as 1.3 The retention time of lenalidomide was approximately 2.5 min; Imp Imp-3, and Imp-4 co eluted by addition of aqueous ammonia solution. The tailing factor of lenalidomide was 1.1. RS between Imp-A and Imp-B was 2.2; RS between Imp-3 and LLM was 2. Table 4.1: Results from different method development trials Acharya Nagarjuna University, Guntur 123
20 Compound No. of theoretical USP USP tailing plates, N (USP Resolution factor tangent method) Lenalidomide Imp-B Imp-A Table 4.2: Results from system-suitability test S No. Sample name Average Retention time (minutes) % Interference (Respective to Lenalidomide and Impurities) 1 Diluent , NO 2 Placebo NO 3 Lenalidom ide NA 4 Impurity A NA 5 Impurity B NA Table 4.3: Results from specific and selectivity Acharya Nagarjuna University, Guntur 124
21 Sample Imp-A Imp-B Purity by Assay by HPLC HPLC Bulk drug; batch no ND Bulk drug; batch no ND Bulk drug; batch no ND Drug product; batch no ND Drug product; batch no ND Drug product; batch no. CDGH0022 ND Table 4.4: Results (%) from batch analysis Duration Related substance by HPLC Imp-A Imp-B Total impurities Assay by HPLC Bulk drug batch no Initial ND ND days ND days ND days ND Drug product batch no Initial ND ND days ND days ND days ND Remarks Table 4.5: Results (%) from accelerated stability study (storage conditions 40 ± 2 0 C and RH 75 ± 5%) Acharya Nagarjuna University, Guntur 125
22 Related Duration Assay substance by Total by HPLC impurities HPLC Imp-A Imp-B Bulk drug batch no Initial ND ND days ND days ND days ND Drug product batch no Initial ND ND days ND days ND days ND Remarks Table 4.6: Results (%) from long-term stability study (storage conditions 25 ± 2 0 C and RH 60 ± 5%) Acharya Nagarjuna University, Guntur 126
23 Variation Different system Waters 2695 Alliance system Agilent 1100 series VWD system RSD (%) for RSD (%) for related assay substances Different column Different analyst Column Column Analyst Analyst Table 4.7: Results from determination of intermediate precision Added (µg) Recovered (µg) Recovery (%) RSD (%) Table 4.8: Results from study of accuracy for bulk drug substance Added (µg) Recove red (µg) Recove ry (%) RSD (%) Table 4.9: Results from study of accuracy for drug product Acharya Nagarjuna University, Guntur 127
24 Condition Temperature (±5 C of optimum temperature) Flow rate (±20% of the optimum flow rate) ph (±0.1 unit of set ph) Resolution Resolution Variation (RS) between (RS) between lenalidomide Imp-B and and Imp-B Imp-A ml / min ml / min Table 4.10: Results from study of robustness Acharya Nagarjuna University, Guntur 128
25 BIBLIOGRAPHY: Bakshi, M., Singh, S., J. Pharm. Biomed. Anal., 28, 6, 2002, Carstensen, J. T., Rhodes, C. T., (ed) (2000) Drug stability principles and practices, 3rd edn., Marcel Dekker, NY Dimopoulos, M. A., Spencer, A., Attal, M., Blood., 106, 6, 2005, International Conference on Harmonization (2003) Stability testing of new drug substances and products Q1A (R2). International Conference on Harmonization., IFPMA, Geneva International Conference on Harmonization (1995) ICH guidelines on validation of analytical procedures., text and methodology Q2 (R1): FDA. Federal Register 60,11260 Kastritis, E., Dimopoulos, M. A., Expert. Opin. Pharmacother., 8, 4, 2007, List, A., Dewald, G., Bennett, J., N. Engl. J. Med., 355, 14, 2006, Mitsiades, C.S., Mitsiades, N., Curr. Opin. Investig. Drugs., 5, 6, 2004, Rajkumar, S. V., Hayman, S. R., Lacy M. Q., Blood., 106, 13, 2005, Richardson, P. G., Blood, E., Mitsiades, C. S., Blood., 108, 10, 2006, Weber, D., Wang, M., Chen, C., Blood., 108, 6, 2006, Acharya Nagarjuna University, Guntur 129
7. Stability indicating analytical method development and validation of Ramipril and Amlodipine in capsule dosage form by HPLC.
7. Stability indicating analytical method development and validation of and in capsule dosage form by HPLC. 7.1 INSTRUMENTS AND MATERIALS USED 7.1.1 INSTRUMENTS 1. Shimadzu LC-2010 CHT with liquid chromatograph
More informationValidation of Stability-Indicating RP-HPLC Method for the Assay of Ibrutinib in Pharmaceutical Dosage form
Validation of Stability-Indicating RP-HPLC Method for the Assay of Ibrutinib in Pharmaceutical Dosage form 8.1 Introduction Ibrutinib (IBR) is an anticancer drug targeting B-cell malignancies (blood cancer
More informationCHAPTER INTRODUCTION OF DOSAGE FORM AND LITERATURE REVIEW
75 CHAPTER 3 DEVELOPMENT AND APPLICATION OF STABILITY-INDICATING HPLC METHOD FOR THE DETERMINATION OF NEVIRAPINE AND ITS IMPURITIES IN COMBINATION DRUG PRODUCT 3.1 INTRODUCTION OF DOSAGE FORM AND LITERATURE
More informationDETERMINATION OF DRUG RELEASE DURING DISSOLUTION OF NICORANDIL IN TABLET DOSAGE FORM BY USING REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
CHAPTER 9 DETERMINATION OF DRUG RELEASE DURING DISSOLUTION OF NICORANDIL IN TABLET DOSAGE FORM BY USING REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY CHAPTER 9 Determination of drug release during
More informationSTABILITY INDICATING METHOD OF RELATED IMPURITIES IN VENLAFAXINE HYDROCHLORIDE SUSTAINED RELEASE TABLETS
Issn No: 976-39 RESEARCH ARTICLE STABILITY INDICATING METHOD OF RELATED IMPURITIES IN VENLAFAXINE HYDROCHLORIDE SUSTAINED RELEASE TABLETS CHETLAPALLI SATYA SRINIVAS 1, P.RENUKA DEVI 2 and GAMPA VIJAYAKUMAR*
More informationStability-indicating HPLC determination of tolterodine tartrate in pharmaceutical dosage form
Indian Journal of Chemical Technology Vol. 13, May 2006, pp. 242-246 Stability-indicating HPLC determination of tolterodine tartrate in pharmaceutical dosage form Vinay Saxena a *, Zahid Zaheer b & Mazhar
More informationLC Determination of Deferasirox in Pharmaceutical Formulation
ISSN:2230-7346 Available online http://www.jgtps.com Research Article Journal of Global Trends in Pharmaceutical Sciences Vol.1, Issue 1, pp 42-52, October December 2010 LC Determination of Deferasirox
More informationInt. J. Pharm. Sci. Rev. Res., 30(2), January February 2015; Article No. 09, Pages: 63-68
Research Article Stability indicating RP-HPLC Method for Determination of FexoFenadine Hydrochloride and its Related Substances in Active Pharmaceutical Substance Abhay Gupta* 1, Dr. Birendra Srivastava,
More informationA Simple, Novel Validated Stability Indicating RP-HPLC method for estimation of Duloxetine HCl in Capsule Pharmaceutical Formulation
Pharmaceutical Research A Simple, Novel Validated Stability Indicating RP-HPLC method for estimation of Duloxetine HCl in Capsule Pharmaceutical Formulation Manisha Puranik* a, Sailesh Wadher b and Kritika
More informationRP-HPLC Method Development and Validation of Dapagliflozin in Bulk and Tablet formulation
221 IJPAR Volume 2 Issue 4 Oct - Dec -2013 ISSN: 2320-2831 Available Online at: [Research article] RP-HPLC Method Development and Validation of Dapagliflozin in Bulk and Tablet formulation Jeyabaskaran.M
More information2.1 2,3 Dichloro Benzoyl Cyanide (2,3 DCBC) and survey of. manufactured commonly for the bulk drug industry, few references were
. Introduction.,3 Dichloro Benzoyl Cyanide (,3 DCBC) and survey of analytical methods,3-dcbc substance, is the although advanced intermediate,3-dcbc is a of lamotrigine well-known bulk drug chemical manufactured
More informationImpact factor: 3.958/ICV: 4.10 ISSN:
Impact factor: 3.958/ICV: 4.10 ISSN: 0976-7908 99 Pharma Science Monitor 9(4), Oct-Dec 2018 PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES Journal home page: http://www.pharmasm.com
More informationInternational Journal of Pharmacy and Pharmaceutical Sciences Vol 2, Issue 1, 2010
International Journal of Pharmacy and Pharmaceutical Sciences Vol 2, Issue 1, 2010 RP HPLC ESTIMATION OF EZETIMIBE IN TABLET DOSAGE FORMS NAGARAJU. P *, KRISHNACHAITHANYA. K, CHANDRABABU. D, SRINIVAS.
More informationMethod Development and Validation Of Prasugrel Tablets By RP- HPLC
Method Development and Validation Of Prasugrel Tablets By RP- HPLC K.Sonia*, Ndwabe Hamunyare, K.Manikandan Department of Pharmaceutical Analysis, SRM College of Pharmacy, SRM University, Kattankulathur,
More informationDevelopment of Validated Analytical Method of Mefenamic Acid in an Emulgel (Topical Formulation)
Development of Validated Analytical Method of Mefenamic Acid in an Emulgel (Topical Formulation) TEENA OSWAL*, DR.SURYAKANT BHOSALE, DR. SONALI NAIK MET Institute Of Pharmacy Met Complex, Bandra Reclamation,
More informationResearch Article. Identification and characterization of unknown impurity in zolmitriptan tablets by a sensitive HPLC method
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2014, 6(12):548-553 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Identification and characterization of unknown
More informationPraveen kumar.m 1 *, Sreeramulu.J 2. *Corres.author: Mobile no: India.
International Journal of ChemTech Research CODEN( USA): IJCRGG ISSN : 0974-4290 Vol.3, No.1, pp 321-328, Jan-Mar 2011 Development and validation of a Stabilityindicating Reversed-Phase High Performance
More informationResearch Article METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF ELBASVIR AND GRAZOPREVIR BY RP-HPLC
ISSN 2395-3411 Available online at www.ijpacr.com 248 Research Article METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF ELBASVIR AND GRAZOPREVIR BY RP-HPLC Mantha Vebkatesh* and A. Yasodha
More informationJournal of Pharmaceutical and Biomedical Analysis Letters. Analysis Letters
Naga Jyothi. C et al, JPBMAL, 2015, 3(1): 242 246 ISSN: 2347-4742 Journal of Pharmaceutical and Biomedical Analysis Letters Journal Home Page: www.pharmaresearchlibrary.com/jpbmal Research Article Open
More informationMashhour Ghanem 1 and Saleh Abu-Lafi 2 * ABSTRACT ARTICLE INFO
. Journal of Applied Pharmaceutical Science Vol. 3 (10), pp. 051-058, October, 2013 Available online at http://www.japsonline.com DOI: 10.7324/JAPS.2013.31009 ISSN 2231-3354 Validation of a Stability-Indicating
More informationSTABILITY INDICATING RP-HPLC METHOD FOR DETERMINATION OF EPROSARTAN IN PURE AND PHARMACEUTICAL FORMULATION
STABILITY INDICATING RP-HPLC METHOD FOR DETERMINATION OF EPROSARTAN IN PURE AND PHARMACEUTICAL FORMULATION Praveen Kumar.M 1 *, Sreeramulu.J 2 1 Department of chemistry, Rayalaseema University, Kurnool-518002,
More informationVolume 6, Issue 2, January February 2011; Article-015
Research Article DEVELOPMENT AND VALIDATION OF A RP-HPLC METHOD FOR THE DETERMINATION OF DAPOXETINE HYDROCHLORIDE IN PHARMACEUTICAL FORMULATION USING AN EXPERIMENTAL DESIGN Pratik Mehta*, Ujjwal Sahoo,
More informationA RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF PARA- PHENYLENEDIAMINE IN PURE FORM AND IN MARKETED PRODUCTS
A RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF PARA- PHENYLENEDIAMINE IN PURE FORM AND IN MARKETED PRODUCTS CH.MOUNIKA*, M.KINNERA Research Article SIR.C.R.REDDY COLLEGE OF PHARMACEUTICAL SCIENCES, ELURU.
More informationSTABILITY INDICATING RP HPLC METHOD FOR ANALYSIS OF DORZOLAMIDE HCl IN THE BULK DRUG AND IT S PHARMACEUTICAL DOSAGE FORM
International Journal of Pharmacy and Pharmaceutical Sciences ISSN- 0975-1491 Vol 3, Issue 3, 2011 Research Article STABILITY INDICATING RP HPLC METHOD FOR ANALYSIS OF DORZOLAMIDE HCl IN THE BULK DRUG
More informationPelagia Research Library
Available online at www.pelagiaresearchlibrary.com Der Chemica Sinica, 2011, 2 (2): 230-239 ISSN: 0976-8505 CODEN (USA) CSHIA5 Stress degradation studies on Iloperidone and development of a stabilityindicating
More informationA Stability Indicating UPLC Method for Candesartan in Bulk Drug Samples
American Journal of Analytical Chemistry, 2012, 3, 704-709 http://dx.doi.org/10.4236/ajac.2012.310093 Published nline ctober 2012 (http://www.scirp.org/journal/ajac) A Stability Indicating UPLC Method
More informationVALIDATION OF A UPLC METHOD FOR A BENZOCAINE, BUTAMBEN, AND TETRACAINE HYDROCHLORIDE TOPICAL SOLUTION
VALIDATION OF A UPLC METHOD FOR A BENZOCAINE, BUTAMBEN, AND TETRACAINE HYDROCHLORIDE TOPICAL SOLUTION Andrew J. Aubin and Tanya L. Jenkins Waters Corporation, Milford, MA, USA INTRODUCTION Benzocaine (4-Aminobenzoic
More informationAnalytical CHEMISTRY
ISSN : 0974-7419 Validation of stability indicating rp-hplc method for the assay of ibrutinib in pharmaceutical dosage form Sureshbabu Kapavarapu 2, Ramu Golkonda 3, Rambabu Chintala 1 * 1 Department of
More informationStability Indicating RP-HPLC Method for Determination of Valsartan in Pure and Pharmaceutical Formulation
ISSN: 0973-4945; CODEN ECJHAO E- Chemistry http://www.e-journals.net 2010, 7(1), 246-252 Stability Indicating RP-HPLC Method for Determination of Valsartan in Pure and Pharmaceutical Formulation S. K.
More informationDevelopment and Validation of Stability-Indicating RP-HPLC Method for Estimation of Atovaquone
Available online at www.ijpcr.com International Journal of Pharmaceutical and Clinical Research 2012; 4(4): 68-72 Research Article ISSN 0975 1556 Development and Validation of Stability-Indicating RP-HPLC
More informationMethod Development and Validation for the Estimation of Darunavir in Rat Plasma by RP-HPLC
World Journal of Pharmaceutical Sciences ISSN (Print): 2321-3310; ISSN (Online): 2321-3086 Published by Atom and Cell Publishers All Rights Reserved Available online at: http://www.wjpsonline.org/ Original
More informationRP-HPLC Method for the Determination of Cinitapride in the Presence of its Degradation Products in Bulk Drug
ISSN: 0973-4945; CODEN ECJHAO E- Chemistry http://www.e-journals.net 2010, 7(1), 311-319 RP-HPLC Method for the Deteration of Cinitapride in the Presence of its Degradation Products in Bulk Drug S.M.N.ROY
More informationPharmacophore 2011, Vol. 2 (4), ISSN Pharmacophore. (An International Research Journal)
Pharmacophore 2011, Vol. 2 (4), 232-238 ISSN 2229 5402 Pharmacophore (An International Research Journal) Available online at http://www.pharmacophorejournal.com/ Original Research Paper SIMULTANEOUS ANALYSIS
More informationScholars Research Library
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2011, 3 (6):49-57 (http://scholarsresearchlibrary.com/archive.html) ISSN 0974-248X USA CODEN: DPLEB4
More informationDevelopment and Validation of a HPLC Method for Chlorphenamine Maleate Related Substances in Multicomponents Syrups and Tablets
Development and Validation of a HPLC Method for Chlorphenamine Maleate Related Substances in s Syrups and Tablets Larisa Alagić-Džambić*, Midhat Vehabović, Edina Čekić, Mirsad Džambić Development Department,
More informationInternational Journal of Pharmaceutical Research & Analysis
149 International Journal of Pharmaceutical Research & Analysis e-issn: 2249 7781 Print ISSN: 2249 779X www.ijpra.com RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF AMBROXOL HYDROCHLORIDE
More informationPelagia Research Library
Available online at www.pelagiaresearchlibrary.com Der Pharmacia Sinica, 2014, 5(1):34-39 ISSN: 0976-8688 CODEN (USA): PSHIBD Advance simultaneous determination of paracetamol, thiocolchicoside and aceclofenac
More informationDepartment of Chemistry, JNTUACE, Kalikiri
Method Development and Validation of Aegle marmeleous M. Swetha 1*, N. Saritha 1, N. Devanna 2 1 Department of Chemistry, JNTUACE, Kalikiri.-517234 2 Department of Chemistry, JNTUA, Anthapuramu -515002
More informationJournal of Chemical and Pharmaceutical Research
Available on line www.jocpr.com Journal of Chemical and Pharmaceutical Research ISSN No: 0975-7384 CODEN(USA): JCPRC5 J. Chem. Pharm. Res., 2011, 3(2):274-279 A simple and validated reverse phase HPLC
More informationResearch Article Available online at
Research Article Available online at www.jgtps.com ISSN: 2230-7346 Volume- 5, Issue -2, pp-1522-1527- April June (2014) DEVELOPMENT AND VALIDATION OF AN RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF CITICOLINE
More informationAvailable online Research Article
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2013, 5(12):1230-1236 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Rapid simultaneous determination of naproxen
More informationDevelopment of A Rapid and Sensitive HPLC Assay Method for Lenalidomide Capsules and its Related Substances
ISSN: 0973-4945; CDEN ECJHA E-Journal of Chemistry http://www.ejchem.net 2012, 9(3), 1165-1174 Development of A Rapid and Sensitive HPLC Assay Method for Lenalidomide Capsules and its Related Substances
More informationDEVELOPMENT AND VALIDATION OF A STABILITY-INDICATING RP-HPLC METHOD FOR ASSAY OF IRBESARTAN IN PURE AND PHARMACEUTICAL DOSAGE FORM
Research Article DEVELOPMENT AND VALIDATION OF A STABILITY-INDICATING RP-HPLC METHOD FOR ASSAY OF IRBESARTAN IN PURE AND PHARMACEUTICAL DOSAGE FORM Praveen kumar.m 1 *, Sreeramulu.J 2 1 Department of Chemistry,
More informationStability indicating RP-HPLC method for determination of azilsartan medoxomil in bulk and its dosage form
IJPAR Vol.3 Issue 4 Oct-Dec-2014 Journal Home page: ISSN: 2320-2831 Research article Open Access Stability indicating RP-HPLC method for determination of azilsartan medoxomil in bulk and its dosage form
More informationValidated RP-HPLC Method for Estimation of Cefprozil in Tablet Dosage Form
International Journal of PharmTech Research CDEN (USA): IJPRIF ISSN : 0974-4304 Vol.4, No.3, pp 1228-1232, July-Sept 2012 Validated RP-HPLC Method for Estimation of Cefprozil in Tablet Dosage Form Manzoor
More informationJournal of Chemical and Pharmaceutical Research
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research ISS o: 0975-7384 CDE(USA): JCPRC5 J. Chem. Pharm. Res., 2011, 3(6):987-996 A Validated stability indicating LC method of assay
More informationDevelopment and Validation of a HPLC Method for Determination of Anastrozole in Tablet Dosage Form
ISSN: 0973-4945; CODEN ECJHAO E- Chemistry http://www.e-journals.net 2011, 8(2), 794-797. Development and Validation of a HPLC Method for Determination of Anastrozole in Tablet Dosage Form D.SATHIS KUMAR
More informationChapter-4 EXPERIMENTAL WORK BY RP-HPLC
Chapter-4 EXPERIMENTAL WORK BY RP-HPLC 4.0 EXPERIMENTAL WORK BY RP-HPLC 4.1. DEVELOPMENT AND VALIDATION OF AN RP-HPLC METHOD FOR THE DETERMINATION OF NIFLUMIC ACID 4.1.1. MATERIALS AND METHODS OF NIFLUMIC
More informationDEVELOPMENT AND VALIDATION OF RP-HPLC METHOD TO DETERMINE CINITAPRIDE HYDROGEN TARTARATE IN BULK AND PHARMACEUTICAL FORMULATION
Research Article ISSN:2230-7346 Journal of Global Trends in Pharmaceutical Sciences Vol.3, Issue 2, pp -619-627, April June 2012 DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD TO DETERMINE CINITAPRIDE HYDROGEN
More informationInternational Research Journal of Pharmaceutical and Applied Sciences Available online at Int. Res J Pharm. App Sci.
International Research Journal of Pharmaceutical and Applied Sciences Available online at www.irjpas.com Int. Res J Pharm. App Sci., 2012; 2(4):49-55 Research Article Method development and validation
More informationJournal of Advanced Scientific Research DEVELOPMENT AND VALIDATION OF STABILITY-INDICATING RP-HPLC METHOD FOR ESTIMATION OF DABIGATRAN ETEXILATE
Damle et al, J Adv Sci Res, 2014, 5(3): 39-44 39 Journal of Advanced Scientific Research Available online through http://www.sciensage.info/jasr ISSN 0976-9595 Research Article DEVELOPMENT AND VALIDATION
More informationPHARMA SCIENCE MONITOR
PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES DEVELOPMENT AND VALIDATION OF NEW ANALYTICAL METHOD FOR QUANTITATIVE ESTIMATION OF RACECADOTRIL AS AN ACTIVE PHAMACEUTICAL INGREDIENT
More informationSIMULTANEOUS RP HPLC DETERMINATION OF CAMYLOFIN DIHYDROCHLORIDE AND PARACETAMOL IN PHARMACEUTICAL PREPARATIONS.
Ind. J. Anal. Chem Vol. 7 11. 2008 SIMULTANEOUS RP HPLC DETERMINATION OF CAMYLOFIN DIHYDROCHLORIDE AND PARACETAMOL IN PHARMACEUTICAL PREPARATIONS. Authors for correspondence : R. R. Singh1*, M. V. Rathnam,
More informationQuantitation of Sodium Bisulfite in Pharmaceutical Formulation by RP-HPLC
Quantitation of Sodium Bisulfite in Pharmaceutical Formulation by RP-HPLC Chapter-3 Overview: The present chapter deals with the determination of sodium bisulfite (inorganic compound) as antioxidant in
More informationSimultaneous estimation and validation of bromhexine and cephalexin in bulk and pharmaceutical dosage form by RP-HPLC method
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2014, 6 (6):315-321 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4
More informationDevelopment and validation of RP-LC method for lisinopril dihydrate in bulk and its pharmaceutical formulations
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2015, 7 (7):340-344 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CDEN: DPLEB4
More informationDevelopment And Validation Of Rp-Hplc Method For Determination Of Velpatasvir In Bulk
International Journal of Engineering Science Invention (IJESI) ISSN (Online): 2319 6734, ISSN (Print): 2319 6726 www.ijesi.org PP. 36-41 Development And Validation Of Rp-Hplc Method For Determination Of
More informationNovus International Journal of Analytical Innovations 2012, Vol. 1, No. 3
Novus International Journal of Analytical Innovations 2012, Vol. 1, No. 3 ISSN 2278-6953 www.novusscientia.org Accepted on October 22, 2012 RP-HPLC method for simultaneous estimation of Avitriptan and
More informationInternational Journal of Current Trends in Pharmaceutical Research. International Journal of Current Trends in Pharmaceutical Research
International Journal of Current Trends in Pharmaceutical Research Journal Home Page: www.pharmaresearchlibrary.com/ijctpr Research Article Open Access Development and Validation Levofloxacin Andambroxol
More informationINDICATING LIQUID CHROMATOGRAPHIC METHOD FOR QUANTIFICATION OF CIPROFLOXACIN HCL, ITS RELEATED SUBSTANCE AND TINIDAZOLE IN TABLET DOSAGE FORM
Innovare Academic Sciences International Journal of Pharmacy and Pharmaceutical Sciences ISSN- 0975-1491 Vol 6, Issue 5, 2014 Original Article VALIDATED STABILITY INDICATING LIQUID CHROMATOGRAPHIC METHOD
More informationNew Validated RP-HPLC Method for Quantification of Rupatadine Fumarate Impurities in Solid Dosage Form Supported By Forced Degradation Studies
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2016, 8 (14):66-72 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4
More informationDevelopment and Validation of Sensitive RP-HPLC Method for the Estimation of Glibenclamide in Pure and Tablet Dosage Forms
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2016, 8 (15):101-106 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4
More informationChapter 4: Verification of compendial methods
Chapter 4: Verification of compendial methods Introduction In order to ensure accurate and reliable test results, the quality control laboratory (QCL) needs to use analytical methods (and accompanying
More informationSarojamma. M et al, JGTPS, 2015, Vol. 6(2):
ISSN: 2230-7346 Sarojamma. M et al. / JGTPS / 6(2)-(2015) 2546 2551 (Research Article) Journal of Global Trends in Pharmaceutical Sciences Journal home page: www.jgtps.com RP-HPLC ASSAY METHOD DEVELOPMENT
More informationSection (i): Brief account of Dexlansoprazole
Section (i): Brief account of Dexlansoprazole Dexlansoprazole (DLP) is the R-enantiomer of lansoprazole (a racemic mixture of the R- and S-enantiomers). It is chemically (R)-(+)2-([3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-
More informationJournal of Chemical and Pharmaceutical Research, 2012, 4(6): Research Article. Estimation of zaleplon by a new RP-HPLC method
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2012, 4(6):3010-3014 Research Article ISS : 0975-7384 CODE(USA) : JCPRC5 Estimation of zaleplon by a new RP-HPLC method Tentu.
More informationDEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR QUANTITATIVE ANALYSIS OF GABAPENTIN IN PURE AND PHARMACEUTICAL FORMULATIONS
Int. J. Chem. Sci.: 10(4), 2012, 2209-2217 ISSN 0972-768X www.sadgurupublications.com DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR QUANTITATIVE ANALYSIS OF GABAPENTIN IN PURE AND PHARMACEUTICAL FORMULATIONS
More informationSravani and Haritha Indian Journal of Research in Pharmacy and Biotechnology ISSN: (Print) ISSN: (Online)
A new development and validated RP-HPLC method for the assay and related substances of Itraconazole in capsule dosage form Sarvani Paruchuri*, Haritha Pavani K Nimra College of Pharmacy, Vijayawada, Andhra
More informationIn the present analytical project, an attempt has been made to develop a simple, economical and reliable liquid
ISSN: 0975-766X CODEN: IJPTFI Available Online through Research Article www.ijptonline.com STABILITY INDICATING HPLC METHOD FOR THE DETERMINATION OF GATIFLOXACIN IN PHARMACEUTICAL FORMULATIONS Syeda kulsum,
More informationAripiprazole is a quinolinone derivative with the chemical name 7-[4- [4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro-2(1H)
147 5.0 INTRODUCTION Aripiprazole is a quinolinone derivative with the chemical name 7-[4- [4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro-2(1H) quinolinone. Aripiprazole is a psychotropic agent
More informationSIMPLE AND SENSITIVE VALIDATED REVERSE PHASE HPLC-UV METHOD FOR THE DETERMINATION OF LYMECYCLINE IN PHARMACEUTICAL DOSAGE FORMS
IJPSR (2012), Vol. 3, Issue 07 (Research Article) Received on 26 March, 2012; received in revised form 25 June, 2012; accepted 28 June, 2012 SIMPLE AND SENSITIVE VALIDATED REVERSE PHASE HPLC-UV METHOD
More informationMETHOD DEVELOPMENT AND VALIDATION OF RALTEGRAVIR POTASSIUM AND RILPIVIRINE HCL BY HPLC AND HPTLC METHODS
CHAPTER 6 METHOD DEVELOPMENT AND VALIDATION OF RALTEGRAVIR POTASSIUM AND RILPIVIRINE HCL BY HPLC AND HPTLC METHODS School of Pharmaceutical Sciences, Vels University 106 METHOD DEVELOPMENT AND VALIDATION
More informationDevelopment and validation a RP-HPLC method: Application for the quantitative determination of quetiapine fumarate from marketed bulk tablets
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2016, 8(1):142-146 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Development and validation a RP-HPLC method: Application
More informationINTERNATIONAL RESEARCH JOURNAL OF PHARMACY
INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Research Article STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF CEFIXIME
More informationReverse Phase High Performance Liquid Chromatography method for determination of Lercanidipine hydrochloride in bulk and tablet dosage form
Research Article ISSN: 0974-6943 M.V.Kumudhavalli et al. / Journal of Pharmacy Research 2014,8(11), Available online through http://jprsolutions.info Reverse Phase High Performance Liquid Chromatography
More informationSimultaneous Estimation of Residual Solvents (Isopropyl Alcohol and Dichloromethane) in Dosage Form by GC-HS-FID
Asian Journal of Chemistry Vol. 21, No. 3 (2009), 1739-1746 Simultaneous Estimation of Residual Solvents (Isopropyl Alcohol and Dichloromethane) in Dosage Form by GC-HS-FID PRAVEEN KUMAR BALIYAN*, R.P.
More informationDevelopment and Validation of Stability Indicating RP-HPLC Method for the Determination of Anagrelide HCl in Pharmaceutical Formulation
ISSN 0976 3333 Available Online at www.ijpba.info International Journal of Pharmaceutical & Biological Archives 2013; 4(2): 342-346 ORIGINAL RESEARCH ARTICLE Development and Validation of Stability Indicating
More informationJournal of Drug Delivery and Therapeutics
Available online on 15.01.2018 at http://jddtonline.info Journal of Drug Delivery and Therapeutics Open Access to Pharmaceutical and Medical Research 2011-17, publisher and licensee JDDT, This is an Open
More informationKEYWORDS: Acetaminophen, Doxylamine succinate, Dextromethorphan hydrobromide.
International Journal of Pharmaceutical Science Invention ISSN (Online): 2319 6718, ISSN (Print): 2319 670X Volume 3 Issue 7 July 2014 PP.08-12 Analytical method development and validation of acetaminophen,
More informationJournal of Chemical and Pharmaceutical Research, 2017, 9(1): Research Article
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2017, 9(1):118-122 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Development and Validation of High Performance Liquid
More informationDissolution study and method validation of alprazolam by high performance liquid chromatography method in pharmaceutical dosage form
Research Journal of Recent Sciences ISSN 2277-252 Dissolution study and method validation of alprazolam by high performance liquid chromatography method in pharmaceutical dosage form Abstract Rele Rajan
More informationDepartment of Quality Assurance, Luqman College of Pharmacy, GULBARGA (K.S.) INDIA ABSTRACT
Int. J. Chem. Sci.: 12(3), 2014, 871-879 ISSN 0972-768X www.sadgurupublications.com DEVELPMENT AND VALIDATIN F A RAPID RP HPLC METHD FR THE DETERMINATIN F CINITAPRIDE HYDRGEN TARTARATE IN PURE AND ITS
More informationDEVELOPMENT AND VALIDATION OF NEW RP-HPLC METHOD FOR THE DETERMINATION OF AFLOQUALONE IN HUMAN PLASMA AND FORMULATION
INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article DEVELOPMENT AND VALIDATION OF NEW RP-HPLC METHOD FOR THE DETERMINATION OF AFLOQUALONE IN HUMAN
More informationDevelopment and validation of RP-HPLC method for the analysis of carbofuran and in its formulations
Available online at www.derpharmachemica.com Scholars Research Library Der Pharma Chemica, 2013, 5(1):313-319 (http://derpharmachemica.com/archive.html) ISSN 0975-413X CODEN (USA): PCHHAX Development and
More informationSaudi Journal of Medical and Pharmaceutical Sciences
Saudi Journal of Medical and Pharmaceutical Sciences Scholars Middle East Publishers Dubai, United Arab Emirates Website: http://scholarsmepub.com/ ISSN 2413-4929 (Print) ISSN 2413-4910 (Online) Stability
More informationANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF IVABRADINE HCL IN BULK AND FORMULATION
ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF IVABRADINE HCL IN BULK AND FORMULATION Gauri Korgaonkar *, Vaishali B. Jadhav, Ashish Jain Shri d.d. vispute college of pharmacy & research center, Panvel,
More informationA VALIDATED STABILITY-INDICATING HPLC ASSAY DETERMINATION OF FESOTERODINE FUMARATE
ISSN: 0974-1496 CODEN: RJCABP http://www.rasayanjournal.com A VALIDATED STABILITY-INDICATING HPLC ASSAY METHOD FOR DETERMINATION OF FESOTERODINE FUMARATE B.V.Rami Reddy 1,2, B.S.Reddy 2, M.Sravan Kumar
More informationJournal of Chemical and Pharmaceutical Research, 2017, 9(10): Research Article
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2017, 9(10):286-293 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Development and Validation of UPLC Method for the
More information4.1 MATERIALS 4.2 EQUIPMENTS
4.1 MATERIALS 1. Aceclofenac Moraceae Pharma Ltd., Uttarakhand, India 2. Diclofenac Arti Drugs Ltd., Mumbai, India 3. Paracetamol Moraceae Pharma Ltd., Uttarakhand, India 4. Para-aminophenol Hema Pharmaceuticals
More informationJ Pharm Sci Bioscientific Res (4): ISSN NO
Development and Validation of Stability Indicating Analytical Method for Simultaneous Estimation of Perindopril and Potassium in Their Combined Marketed Dosage Form ABSTRACT: Gurjeet Kaur*, Nikhil Patel
More informationANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF STABILITY- INDICATING ASSAY METHOD OF TICAGRELOR TABLETS BY USING RP-HPLC
wjpmr, 2017,3(10), 235-241 SJIF Impact Factor: 4.103 WORLD JOURNAL OF PHARMACEUTICAL AND MEDICAL RESEARCH www.wjpmr.com Research Article ISSN 2455-3301 WJPMR ANALYTICAL METHOD DEVELOPMENT AND VALIDATION
More informationARTEMETHER AND LUMEFANTRINE TABLETS: Final text for addition to The International Pharmacopoeia (July 2008)
July 2008 ARTEMETER AND LUMEFANTRINE TABLETS: Final text for addition to The International Pharmacopoeia (July 2008) This monograph was adopted at the Forty-second W Expert Committee on Specifications
More informationNEVIRAPINE ORAL SUSPENSION Final text for addition to The International Pharmacopoeia (February 2009)
February 2009. NEVIRAPINE ORAL SUSPENSION Final text for addition to The International Pharmacopoeia (February 2009) This monograph was adopted at the Forty-third WHO Expert Committee on Specifications
More informationInternational Journal of Pharma Research and Health Sciences. Available online at
CODEN (USA)-IJPRUR, e-issn: 2348-6465 International Journal of Pharma Research and Health Sciences Available online at www.pharmahealthsciences.net Original Article Method Development and Validation for
More informationA STABILITY INDICATING RP-HPLC METHOD FOR ESTIMATION OF DABIGATRAN IN PURE AND PHARMACEUTICAL DOSAGE FORMS
A STABILITY INDICATING RP-HPLC METHOD FOR ESTIMATION OF DABIGATRAN IN PURE AND PHARMACEUTICAL DOSAGE FORMS Mr. BRC Sekhar Reddy, Dr. Nallagatla. Vijaya Bhaskar Rao Research Scholar, Department of Chemistry,
More informationResearch Article. Figure 1. Chemical structure of doxofylline. Indonesian J. Pharm. Vol. 24 No. 1 : ISSN-p :
Research Article Indonesian J. Pharm. Vol. 24 No. 1 : 14 21 ISSN-p : 0126-1037 DEVELOPMENT AND VALIDATION OF LIQUID CHROMATOGRAPHY AND SPECTROSCOPIC METHODS FOR THE ANALYSIS OF DOXOFYLLINE IN PHARMACEUTICAL
More informationRadhakrishnan K. et al. / International Journal of Pharmacy & Therapeutics, 3(1), 2012, e- ISSN Print ISSN
e- ISSN 0976-0342 Print ISSN 2229-7456 International Journal of Pharmacy & Therapeutics 73 Journal homepage: www.ijptjournal.com IJPT METHOD DEVELOPMENT AND PARTIAL VALIDATION OF THE RIVASTIGMINE DRUG
More informationZero And First Order Derivative Spectrophotometric Methods For Determination Of Dronedarone In Pharmaceutical Formulation
International Journal of PharmTech Research CDEN (USA): IJPRIF ISSN : 0974-4304 Vol.5, No.1, pp 217-221, Jan-Mar 2013 Zero And First rder Derivative Spectrophotometric Methods For Determination f Dronedarone
More informationAppendix II- Bioanalytical Method Development and Validation
A2. Bioanalytical method development 1. Optimization of chromatographic conditions Method development and optimization of chromatographic parameters is of utmost important for validating a method in biological
More informationPelagia Research Library
Available online at www.pelagiaresearchlibrary.com Der Pharmacia Sinica, 2015, 6(11):19-27 ISSN: 0976-8688 CODEN (USA): PSHIBD Development and validation of stability indicating high performance liquid
More information